Biology Reference
In-Depth Information
Ashburner, M., and Novitski, E. (1976). The Genetics and Biology of Drosophila. London, Academic
Press.
Auluck, P. K., and Bonini, N. M. (2002). Pharmacological prevention of Parkinson disease in
Drosophila. Nat. Med. 8, 1185-1186.
Auluck, P. K., Chan, H. Y., Trojanowski, J. Q., Lee, V. M., and Bonini, N. M. (2002). Chaperone
suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295,
865-868.
Auluck, P. K., Meulener, M. C., and Bonini, N. M. (2005). Mechanisms of suppression of
{alpha}-synuclein neurotoxicity by geldanamycin in Drosophila. J. Biol. Chem. 280, 2873-2878.
Bayersdorfer, F., Voigt, A., Schneuwly, S., and Botella, J. A. (2010). Dopamine-dependent neuro-
degeneration in Drosophila models of familial and sporadic Parkinson's disease. Neurobiol. Dis. 40
(1), 113-119.
Bellen, H. J., Levis, R. W., Liao, G., He, Y., Carlson, J. W., Tsang, G., Evans-Holm, M.,
Hiesinger, P. R., Schulze, K. L., Rubin, G. M.,
. (2004). The BDGP gene disruption project:
Single transposon insertions associated with 40% of Drosophila genes.
et al
Genetics 167, 761-781.
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E.,
Hersheson, J. S., Betts, J., Klopstock, T.,
. (2006). High levels of mitochondrial DNA
deletions in substantia nigra neurons in aging and Parkinson disease.
et al
Nat. Genet. 38, 515-517.
Bennett, M. C. (2005). The role of alpha-synuclein in neurodegenerative diseases.
Pharmacol. Ther.
105, 311-331.
Bernal, A., and Kimbrell, D. A. (2000). Drosophila Thor participates in host immune defense and
connects a translational regulator with innate immunity.
Proc. Natl. Acad. Sci. USA 97,
6019-6024.
Bier, E. (2005). Drosophila, the golden bug, emerges as a tool for human genetics.
Nat. Rev. 6, 9-23.
Birman, S., Morgan, B., Anzivino, M., and Hirsh, J. (1994). A novel and major isoform of tyrosine
hydroxylase in Drosophila is generated by alternative RNA processing.
J. Biol. Chem. 269,
26559-26567.
Blander, G., and Guarente, L. (2004). The Sir2 family of protein deacetylases. Annu. Rev. Biochem.
73, 417-435.
Bogaerts, V., Nuytemans, K., Reumers, J., Pals, P., Engelborghs, S., Pickut, B., Corsmit, E.,
Peeters, K., Schymkowitz, J., De Deyn, P. P., et al. (2008). Genetic variability in the mitochondrial
serine protease HTRA2 contributes to risk for Parkinson disease. Hum. Mutat. 29, 832-840.
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C.,
Squitieri, F., Ibanez, P., Joosse, M., et al. (2003). Mutations in the DJ-1 gene associated with
autosomal recessive early-onset parkinsonism. Science 299, 256-259.
Botella, J. A., Bayersdorfer, F., and Schneuwly, S. (2008). Superoxide dismutase overexpression
protects dopaminergic neurons in a Drosophila model of Parkinson's disease. Neurobiol. Dis. 30,
65-73.
Boutros, M., Kiger, A. A., Armknecht, S., Kerr, K., Hild, M., Koch, B., Haas, S. A., Paro, R., and
Perrimon, N. (2004). Genome-wide RNAi analysis of growth and viability in Drosophila cells.
Science 303, 832-835.
Bradham, C. A., and McClay, D. R. (2006). p38 MAPK is essential for secondary axis specification
and patterning in sea urchin embryos.
Development 133, 21-32.
Brand, A. H., and Perrimon, N. (1993). Targeted gene expression as a means of altering cell fates and
generating dominant phenotypes.
Development 118, 401-415.
Budnik, V., and White, K. (1988). Catecholamine-containing neurons in
Drosophila melanogaster
:
J. Comp. Neurol. 268, 400-413.
Cha, G. H., Kim, S., Park, J., Lee, E., Kim, M., Lee, S. B., Kim, J. M., Chung, J., and Cho, K. S.
(2005). Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila.
Proc. Natl. Acad. Sci. USA 102, 10345-10350.
Distribution and development.
